Alnylam (ALNY) PT Raised to $205 at Oppenheimer, Shares Look Attractive Into 2022 Business and Catalysts
February 11, 2022 5:13 AM
Oppenheimer analyst Leland Gershell raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $205.00 (from $200.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
